arrow
J

Jie Zhou

The University of Hong Kong
H指数:54
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The plant microbiome: From ecological foundations to precision microbial engineering for sustainable agriculture

植物微生物组:从生态学基础到可持续农业的精准微生物工程

iMeta
IF33.2
2026-08-040
OAAI
Cattle and human organoids reveal 2.3.4.4b H5N1 cross-species transmission potential and neuraminidase-specific neutralizing antibodies in humans

牛和人类类器官揭示2.3.4.4b H5N1的跨种传播潜力及神经氨酸酶特异性中和抗体在人体中的存在

2026-07-080
OAAI
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo

作者更正:一种口服可用的Mpro/TMPRSS2双特异性抑制剂,具有体内强效抗冠状病毒疗效

2025-12-150
OAAI
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1

SARS-CoV-2 JN.1衍生变体 (包括JN.1.7、KP.2、KP.3和KP.3.1.1) 的致病性、病毒学特征和免疫逃避

2025-12-110
OAAI
Enhanced replication of a contemporary avian influenza A H9N2 virus in human respiratory organoids

当代禽流感A H9N2病毒在人呼吸道类器官中的增强复制

2025-11-030
OAAI
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo

一种口服可用的Mpro/TMPRSS2双特异性抑制剂,具有体内强效抗冠状病毒活性

2025-07-160
OA
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3

SARS-CoV-2 BA.2.86/JN.1和EG.5.1/HK.3的谱系特异性致病性,免疫逃逸和病毒学特征

2024-10-091
OAAI
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower tract

SARS-CoV-2 Omicron post-BA.2/5亚型在上下道的复制和内在致病性的不同轨迹

2024-01-015
OAAI